down arrow

Fredun Pharma

43
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
654.95
9.85 (1.53%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023

Compare Profit and Loss Results of Fredun Pharma
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
348.00
9,264.00
-8,916.00
-96.24%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
348.00
9,264.00
-8,916.00
-96.24%
Expenditure (Ex Depriciation)
Stock Adjustments
-22.00
-25.00
3.00
12.00%
Raw Materials Consumed
282.00
2,933.00
-2,651.00
-90.39%
Power & Fuel Cost
4.00
70.00
-66.00
-94.29%
Employee Cost
12.00
1,982.00
-1,970.00
-99.39%
Operating Expenses
10.00
143.00
-133.00
-93.01%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
806.00
-801.00
-99.38%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
136.00
-135.00
-99.26%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
310.00
6,939.00
-6,629.00
-95.53%
Operating Profit (PBDIT) excl Other Income
37.00
2,325.00
-2,288.00
-98.41%
Other Income
0.00
266.00
-266.00
-100.00%
Operating Profit (PBDIT)
38.00
2,592.00
-2,554.00
-98.53%
Interest
13.00
15.00
-2.00
-13.33%
Profit before Depriciation and Tax
25.00
2,577.00
-2,552.00
-99.03%
Depreciation
3.00
317.00
-314.00
-99.05%
Profit Before Taxation & Exceptional Items
21.00
2,259.00
-2,238.00
-99.07%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
2,259.00
-2,238.00
-99.07%
Provision for Tax
5.00
436.00
-431.00
-98.85%
Profit After Tax
15.00
1,823.00
-1,808.00
-99.18%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
7,868.00
-7,840.00
-99.64%
Profit Available for appropriations
44.00
9,691.00
-9,647.00
-99.55%
Appropriations
44.00
9,691.00
-9,647.00
-99.55%
Equity Dividend (%)
7%
0%
7.00
Earnings Per Share
33.66
45.52
-11.86
-26.05%
Profit And Loss - Net Sales
Net Sales 348.16 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.98 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023

Profit And Loss - Interest
Interest 13.65 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 15.62 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023